
Conducting early phase oncology clinical trials: key considerations
Early phase oncology trials are the first stage in testing new cancer treatments. This usually encompasses phase I and phase…
Discover the latest in clinical development, trials and clinical data management, from our in-house experts. Available on demand, now. Why not also explore our clinical white papers for even more information?
Following our highly popular webinar, How to Take an Oncology Drug Into the Clinic, Senior Medical Director at Simbec-Orion, Dr Romillie Cruz talked with Professor Sarah Blagden, Professor of Medical Oncology, at the University of Oxford about some of the topics raised during the presentation. Role of the ECMC (…
Early phase oncology trials are the first stage in testing new cancer treatments. This usually encompasses phase I and phase…
Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient manner, and achieve market exclusivity…
The science looks promising and you have secured vital funding to take your compound to the clinical stage. What is…